The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
Open accessAbstract
This study shows that induction of tumor-specific CD4+ T cells by vaccination with a specific viral T helper epitope, contained within a synthetic peptide, results in protective immunity against major histocompatibility complex (MHC) class II negative, virus-induced tumor cells. Protection was also induced against sarcoma induction by acutely transforming retrovirus. In contrast, no protective immunity was induced by vaccination with an unrelated T helper epitope. By cytokine pattern analysis, the induced CD4+ T cells were of the T helper cell 1 type. The peptide-specific CD4+ T cells did not directly recognize the tumor cells, indicating involvement of cross-priming by tumor-associated antigen-presenting cells. The main effector cells responsible for tumor eradication were identified as CD8+ cytotoxic T cells that were found to recognize a recently described immunodominant viral gag-encoded cytotoxic T lymphocyte (CTL) epitope, which is unrelated to the viral env-encoded T helper peptide sequence. Simultaneous vaccination with the tumor-specific T helper and CTL epitopes resulted in strong synergistic protection. These results indicate the crucial role of T helper cells for optimal induction of protective immunity against MHC class II negative tumor cells. Protection is dependent on tumor-specific CTLs in this model system and requires cross-priming of tumor antigens by specialized antigen-presenting cells. Thus, tumor-specific T helper epitopes have to be included in the design of epitope-based vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
Matloubian, M., Concepcion, R. J., & Ahmed, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8056-8063.1994 · Cited by 1,157
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Self-citationVisualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
Kearney, E. R., Pape, K. A., Loh, D. Y., & Jenkins, M. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90084-1 · Cited by 946
Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., De Jongh, B. M., Drijfhout, J. W., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230929 · Cited by 825
Self-citationLjunggren, H. G., & Kärre, K. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.1745 · Cited by 736
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.65 · Cited by 725
Greenberg, P. D. (1991) · Advances in Immunology · doi:10.1016/s0065-2776(08)60778-6 · Cited by 603
Alexander, J., Sidney, J., Southwood, S., Ruppert, J., Oseroff, C., Maewal, A., Snoke, K., Serra, H. M., Kubo, R. T., Sette, A., et al. (1994) · Immunity · doi:10.1016/s1074-7613(94)80017-0 · Cited by 523
Cardin, R. D., Brooks, J. W., Sarawar, S. R., & Doherty, P. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.863 · Cited by 501
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
Keene, J.-A., & Forman, J. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.3.768 · Cited by 500
GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKÆMOGENESIS
Lilly, F., Boyse, E. A., & Old, L. J. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91043-8 · Cited by 350
Shimonkevitz, R., Colon, S., Kappler, J. W., Marrack, P., & Grey, H. M. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.2067 · Cited by 346
Bouaboula, M., Legoux, P., Pességué, B., Delpech, B., Dumont, X., Piechaczyk, M., Casellas, P., & Shire, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36687-6 · Cited by 328
Kast, W. M., Roux, L., Curren, J., Blom, H. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D., & Melief, C. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2283 · Cited by 326
Self-citationPeptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.
Toes, R. E., Offringa, R., Blom, R. J., Melief, C. J., & Kast, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7855 · Cited by 292
Self-citationvon Herrath, M. G., Yokoyama, M., Dockter, J., Oldstone, M. B., & Whitton, J. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1072-1079.1996 · Cited by 279
Peptide-induced antiviral protection by cytotoxic T cells.
Schulz, M., Zinkernagel, R. M., & Hengartner, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.991 · Cited by 238
T cell priming versus T cell tolerance induced by synthetic peptides.
Aichele, P., Brduscha-Riem, K., Zinkernagel, R. M., Hengartner, H., & Pircher, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.261 · Cited by 229
Toes, R. E., Blom, R. J., Offringa, R., Kast, W. M., & Melief, C. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3911 · Cited by 208
Self-citationShirai, M., Pendleton, C. D., Ahlers, J., Takeshita, T., Newman, M., & Berzofsky, J. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.549 · Cited by 182
Ossendorp, F., Eggers, M., Neisig, A., Ruppert, T., Groettrup, M., Sijts, A., Mengedé, E., Kloetzel, P.-M., Neefjes, J., Koszinowski, U., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)80488-4 · Cited by 179
Self-citationRejection of mouse sarcoma cells after transfection of MHC class II genes.
Ostrand-Rosenberg, S., Thakur, A., & Clements, V (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.10.4068 · Cited by 171
Mandelboim, O., Vadai, E., Fridkin, M., Katz-Hillel, A., Feldman, M., Berke, G., & Eisenbach, L. (1995) · Nature Medicine · doi:10.1038/nm1195-1179 · Cited by 163
In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help
Fayolle, C., Dériaud, E., & Leclerc, C. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.12.4069 · Cited by 148
Chen, W., Qin, H., Chesebro, B. W., & Cheever, M. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7773-7782.1996 · Cited by 139
Host Genetic Control Of Spontaneous And Induced Immunity To Friend Murine Retrovirus Infection
Chesebro, B. W., Miyazawa, M., & Britt, W. J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.immunol.8.1.477 · Cited by 127
Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides
Gao, X. M., Zheng, B. Q., Liew, F. Y., Brett, S. J., & Tite, J. P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.10.3268 · Cited by 87
Minev, B., McFarland, B. J., Spiess, P. J., Rosenberg, S. A., & Restifo, N. P. (1994) · PubMed · Cited by 83
Schild, H., Norda, M., Deres, K., Falk, K., Rötzschke, O., Wiesmüller, K., Jung, G., & Rammensee, H. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1665 · Cited by 71
Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells
Iwashiro, M., Kondo, T., Shimizu, T., Yamagishi, H., Takahashi, K., Matsubayashi, Y., Masuda, T., Otaka, A., Fujii, N., & Ishimoto, A. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4533-4542.1993 · Cited by 67
Sijts, A. J. A. M., OSSENDORP, F. A., Mengedé, E., van den Elsen, P. J., & Melief, C. J. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.1.106 · Cited by 60
Self-citationFine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells
Shimizu, T., Uenishi, H., Teramura, Y., Iwashiro, M., Kuribayashi, K., Tamamura, H., Fujii, N., & Yamagishi, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.7704-7708.1994 · Cited by 32
Sijts, A. J. A. M., Bruijn, M. L. D., Ressing, M. E., Nieland, J. D., Mengedé, E., Boog, C. J. P., OSSENDORP, F. A., Kast, W. M., & Melief, C. J. M. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.6038-6046.1994 · Cited by 28
Self-citationKondo, T., Uenishi, H., Shimizu, T., Hirama, T., Iwashiro, M., Kuribayashi, K., Tamamura, H., Fujii, N., Fujisawa, R., & Miyazawa, M. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6735-6741.1995 · Cited by 16
Cited by
CD4+ T cell help in cancer immunology and immunotherapy
Borst, J., Ahrends, T., Bąbała, N., Melief, C. J. M., & Kastenmüller, W. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0044-0 · Cited by 1,585
Self-citationSaxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Self-citationMelief, C. J. M., van Hall, T., Arens, R., Ossendorp, F., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,164
Self-citationAdvances in the development of personalized neoantigen-based therapeutic cancer vaccines
Blass, E., & Ott, P. A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00460-2 · Cited by 1,042
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Alspach, E., Lussier, D. M., Miceli, A. P., Kizhvatov, I., DuPage, M., Luoma, A. M., Meng, W., Lichti, C. F., Esaulova, E., Vomund, A. N., et al. (2019) · Nature · doi:10.1038/s41586-019-1671-8 · Cited by 846
Metadata
- Authors
- Ossendorp, F., Mengedé, E., Camps, M., Filius, R., & Melief, C. J. M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-03-02
- Volume
- 187
- Issue
- 5
- Pages
- 693-702
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2063366670
- Cited by
- 610
- References
- 34
- FWCI
- 14.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.